Psychosexual Impairment, Degree of Surgery and Erectile Aids

  • Sanchia S. Goonewardene
  • Raj Persad
Chapter

Abstract

Adverse effects of prostatectomy on sexual function are a known complication post-surgery, despite nerve sparing [1] (n = 1201). Fode et al. [2] demonstrated the impact of penile vibratory stimulation on erectile dysfunction in a well-designed randomised controlled trial [3, 2] (n = 68). (Level 1, recommendation A). The study showed a significant improvement on erectile function with the aid. The findings of the paper are robust however, it does use something that is not used routinely in clinical practice, penile vibratory stimulation.

References

  1. 1.
    Sanda MG, Dunn RL, Michalski J, Sandler HM, Northouse L, Hembroff L, Lin X, Greenfield TK, Litwin MS, Saigal CS, Mahadevan A, Klein E, Kibel A, Pisters LL, Kuban D, Kaplan I, Wood D, Ciezki J, Shah N, Wei JT. Quality of life and satisfaction with outcome among prostate-cancer survivors. N Engl J Med. 2008;358:1250–61.CrossRefGoogle Scholar
  2. 2.
    Fode M, Borre M, Ohl DA, Lichtbach J, Sonksen J. Penile vibratory stimulation in the recovery of urinary continence and erectile function after nerve-sparing radical prostatectomy: a randomized, controlled trial. BJU Int. 2014;114:111–7.CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Fode M, Borre M, Ohl D, Lichtbach J, Sonksen J. Penile vibratory stimulation in the recovery of erectile function and urinary continence after nerve sparing radical prostatectomy: a randomized, controlled trial. J Sex Med. 2014;11:20.Google Scholar
  4. 4.
    Perez MA, Meyerowitz BE, Lieskovsky G, Skinner DG, Reynolds B, Skinner EC. Quality of life and sexuality following radical prostatectomy in patients with prostate cancer who use or do not use erectile aids. Urology. 1997;50:740–6.CrossRefGoogle Scholar
  5. 5.
    D’Amico AV, Whittington R, Malkowicz SB, Schultz D, Blank K, Broderick GA, Tomaszewski JE, Renshaw AA, Kaplan I, Beard CJ, Wein A. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA. 1998;280:969–74.CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Kimura M, Bañez LL, Polascik TJ, Bernal RM, Gerber L, Robertson CN, Donatucci CF, Moul JW. Sexual bother and function after radical prostatectomy: predictors of sexual bother recovery in men despite persistent post-operative sexual dysfunction. Andrology. 2013;1(2):256–61.CrossRefGoogle Scholar
  7. 7.
    Schiavina R, Borghesi M, Dababneh H, Pultrone CV, Chessa F, Concetti S, Gentile G, Vagnoni V, Romagnoli D, Della Mora L, Rizzi S, Martorana G, Brunocilla E. Survival, continence and potency (SCP) recovery after radical retropubic prostatectomy: a long-term combined evaluation of surgical outcomes. Eur J Surg Oncol. 2014;40:1716–23.CrossRefGoogle Scholar
  8. 8.
    Ficarra V, Novara G, Fracalanza S, D’Elia C, Secco S, Iafrate M, Cavalleri S, Artibani W. A prospective, non-randomized trial comparing robot-assisted laparoscopic and retropubic radical prostatectomy in one European institution. BJU Int. 2009;104:534–9.CrossRefGoogle Scholar
  9. 9.
    Ficarra V, Borghesi M, Suardi N, De Naeyer G, Novara G, Schatteman P, De Groote R, Carpentier P, Mottrie A. Long-term evaluation of survival, continence and potency (SCP) outcomes after robot-assisted radical prostatectomy (RARP). BJU Int. 2013;112:338–45.CrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  • Sanchia S. Goonewardene
    • 1
  • Raj Persad
    • 2
  1. 1.The Royal Free Hospital and UCLLondonUnited Kingdom
  2. 2.North Bristol NHS TrustBristolUnited Kingdom

Personalised recommendations